vancomycin has been researched along with abt 492 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cammarata, SK; Duffy, E; Henry, E; Kingsley, J; Lawrence, LE; Mehra, P; Pullman, J | 1 |
| Cammarata, S; Farley, B; Gardovskis, J; Lawrence, L; Ling, R; Pullman, J; Quintas, M; Sun, E | 1 |
| Cammarata, S; Cruz-Saldariagga, M; Lawrence, L; Liang, S; McManus, A; O'Riordan, W; Poromanski, I; Quintas, M; Teras, J | 1 |
| Miller, LG | 1 |
| Pawlak, JM; Saravolatz, LD; Wegner, C | 1 |
3 trial(s) available for vancomycin and abt 492
| Article | Year |
|---|---|
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Fluoroquinolones; Humans; Linezolid; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult | 2016 |
Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aztreonam; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Fluoroquinolones; Humans; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult | 2017 |
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Aztreonam; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult | 2018 |
2 other study(ies) available for vancomycin and abt 492
| Article | Year |
|---|---|
Another New Antibiotic for Skin Infections and Why Infectious Disease Specialists Are Hypocrites.
Topics: Anti-Bacterial Agents; Aztreonam; Double-Blind Method; Fluoroquinolones; Humans; Infections; Specialization; Vancomycin | 2019 |
Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
Topics: Anti-Bacterial Agents; Daptomycin; Fluoroquinolones; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |